ARRY-371797, p38 inhibitor; oral
Sponsors
Pfizer, Array Biopharma, now a wholly owned subsidiary of Pfizer
Conditions
Ankylosing SpondylitisDental PainHealthyLMNA-Related Dilated CardiomyopathyOsteoarthritis of the KneeRheumatoid Arthritis
Phase 1
Phase 2
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
CompletedNCT00542035
Start: 2007-11-11End: 2008-02-11Updated: 2021-02-21
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
CompletedNCT00663767
Start: 2008-04-07End: 2008-06-20Updated: 2021-02-09
A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
TerminatedNCT00811499
Start: 2008-12-16End: 2009-09-29Updated: 2020-10-19
A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee
CompletedNCT01366014
Start: 2011-06-30End: 2012-06-30Updated: 2020-10-14
A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
CompletedNCT02057341
Start: 2014-02-28End: 2016-05-31Updated: 2020-10-14